Tissue-type plasminogen activator—harmful or beneficial?

被引：0
作者：
Denis Vivien
Carine Ali
机构：
[1] INSERM U919,
[2] GIP Cyceron,undefined
来源：
Nature Reviews Neurology | 2012年 / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The introduction of recombinant tissue-type plasminogen activator (tPA) revolutionized stroke treatment, but experimental studies have suggested potential toxic effects of this molecule on various components of the CNS. Two new studies have added further insight into the complex CNS effects of tPA following traumatic brain injury and brain ischaemia.
引用
收藏
页码：538 / 539
页数：1
相关论文
共 22 条
[1]  
Yepes M(2009)Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic Trends Neurosci. 32 48-55
[2]  
Roussel BD(2012)Tissue-type plasminogen activator regulates the neuronal uptake of glucose in the ischemic brain J. Neurosci. 32 9848-9858
[3]  
Ali C(2006)Tissue-type plasminogen activator: a multifaceted modulator of neurotransmission and synaptic plasticity Neuron 50 673-678
[4]  
Vivien D(1999)Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice Circulation 99 2440-2444
[5]  
Wu F(2011)Tissue plasminogen activator prevents white matter damage following stroke J. Exp. Med. 208 1229-1242
[6]  
Samson AL(2010)Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus J. Clin. Invest. 120 2194-2205
[7]  
Medcalf RL(2003)Cell type-specific roles for tissue plasminogen activator released by neurons or microglia after excitotoxic injury J. Neurosci. 23 3234-3242
[8]  
Nagai N(2012)Glutamate controls tPA recycling by astrocytes, which in turn influences glutamatergic signals J. Neurosci. 32 5186-5199
[9]  
De Mol M(undefined)undefined undefined undefined undefined-undefined
[10]  
Lijnen HR(undefined)undefined undefined undefined undefined-undefined
123